Hanaya Raad

Hanaya Raad

Auto-generated profile, based on publicly available information

Hanaya Raad

Oracle France SAS, Paris, France

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2023 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
CAClara Alloza
Clara Alloza
BKBethany Knox
Bethany Knox
HRHanaya Raad
Hanaya Raad
MAMireia Aguilà
Mireia Aguilà
CCCiara Coakley
Ciara Coakley
MBMichael Batech
Michael Batech

26 February 2026 in BMJ Open
Verified
Journal Article
Open access
PDF file
TOTheodora Oikonomidi
Theodora Oikonomidi
HRHanaya Raad
Hanaya Raad
JDJohn Diaz-Decaro
John Diaz-Decaro
HLHu Li
Hu Li
MSMeredith Y Smith
Meredith Y Smith
NNNivantha Naidoo
Nivantha Naidoo
Introduction Artificial intelligence (AI) is rapidly evolving, offering an expanding suite of capabilities that go beyond the traditional focus on prediction and classification. Generative AI (GenAI) and agentic AI could create transformative practices to support real-world evidence (RWE) generation for health research by streamlining studies, accelerating insights and improving decision-making. However, there is no published overview available describing the range of applications in RWE generation. This review aims to describe where and how genAI and agentic AI are applied across the domains of healthcare research tasks for RWE generation. Additionally, to map applications by tasks and methods across the product lifecycle continuum, and to identify emerging gaps and opportunities. Methods and analysis This Living Scoping Review (LSR) will include studies reporting an application and/or evaluation of genAI or agentic AI applied to one or more RWE generation research tasks. Searches will be conducted in Embase, MEDLINE and additional sources (eg, grey literature). Citations will be independently screened by two human senior reviewers for a substantive training dataset and a commercially available screening algorithm (Robot Screener) will complete screening with a human reviewer. The LSR will include reports of studies (primary or reviews) describing and/or evaluating the application of any genAI model for RWE generation in healthcare, in English, published from 1 January 2025 to the date of search. Data will be extracted from all studies included in the LSR by one independent senior reviewer using a piloted template, with 10% quality check by a second senior reviewer. Descriptive statistics will be used to summarise the applications of genAI per RWE research task, and the results of genAI evaluations. Thematic analysis will be used to describe genAI application patterns, trends, gaps and opportunities. The LSR protocol and reports will be updated annually, and findings will be published on a publicly available website (eg, ISPE—the International Society for Pharmacoepidemiology). Ethics and dissemination Ethical approval is not required due to use of previously published data. Planned dissemination includes peer-reviewed publication, presentation and short summaries.